Filter
387
Text search:
mutation
Featured
Recommendations
49
New Publications
95
Language
Document type
No document type
191
Guidelines
76
Studies & Reports
59
Manuals
18
Strategic & Response Plan
12
Fact sheets
12
Training Material
9
Videos
4
Situation Updates
3
Resource Platforms
2
Brochures
1
Countries / Regions
India
23
Global
11
Western and Central Europe
10
Africa
10
Ethiopia
9
South Africa
9
Burkina Faso
7
Cameroon
7
Latin America and the Carribbean
7
Senegal
6
Congo, Democratic Republic of
6
Haiti
6
Germany
6
Nigeria
5
Nepal
5
Tanzania
4
Benin
4
Liberia
3
Mali
3
Zambia
3
Namibia
3
Middle East and North Africa
3
Eastern Europe
3
Guinea
2
Sierra Leone
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Uganda
2
Niger
2
Chad
2
Kenya
2
Rwanda
2
Bangladesh
2
Mozambique
2
Brazil
2
Bolivia
2
Madagascar
2
Russia
2
France
2
Saudi Arabia
1
Togo
1
Zimbabwe
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Syria
1
Cambodia
1
Thailand
1
China
1
Indonesia
1
Mauritania
1
Malawi
1
Sudan
1
Central African Republic
1
Argentina
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
Cuba
1
Ukraine
1
Colombia
1
Honduras
1
Ecuador
1
Botswana
1
El Salvador
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
Myanmar / Burma
1
Chile
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Asia
1
Venezuela
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
123
Clinical Guidelines
53
Public Health
26
Pharmacy & Technologies
13
Key Resources
8
Women & Child Health
6
Capacity Building
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
65
TB
50
HIV
25
AMR
22
Rapid Response
15
Mental Health
15
Pharmacy
15
Planetary Health
11
NTDs
11
Ebola
10
NCDs
9
Refugee
7
Caregiver
6
Disability
4
Polio
2
Zika
2
Natural Hazards
1
Specific Hazards
1
Of the more than 10 million people estimated to have fallen ill with tuberculosis (TB) in 2022, just over 400 000 people developed TB resistant to rifampicin (RIF), and 1.3 million people developed TB resistant isoniazid (INH). Drug resistance must be detected rapidly and accurately to initiate appr
...
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO
...
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
Les maladies infectieuses sont en constante mutation. De nouvelles maladies apparaissent, d’autres qui sont bien connues se propagent ou refont surface, et quelques rares fois, une maladie est éradiquée. Les maladies infectieuses telles que le V
...
Responding to a polio outbreak. Guidelines
recommended
The occurrence of a case of wild polio in a previously polio free area as presently in Syria, whether through importation, laboratory accident, or mutation of vaccine virus (VDPV), should be considered a public health emergency, that requires a rapi
...
Rediscovering Biology
Molecular to Global Perspectives
Accessed: 03.09.2019
French version of "Developing Pharmacy Practice" - WHO/FIP Joint handbook - Ce manuel expose un nouveau paradigme de pratique pharmaceutique. Il a pour but de guider les enseignants en pharmacie pour qu’ils intègrent cette nouvelle pratique pharmaceutique, de former les étudiants
...
Globalization and Health201612:53 DOI: 10.1186/s12992-016-0194-4
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are
...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma
...
Recommandations pour une approche de santé publique
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
Cet article fait partie d’une série de notes explicatives sur la mise au point et la distribution de vaccins.
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to
...
